News on diseases and Moderna
ShareAnalyze the latest news on diseases and Moderna, extract the entire dataset or get visualizations.
Related dashboards:
Latest news
Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views
Moderna and other vaccines stocks are down after the FDA's top vaccine official resigns
Pfizer, Moderna, and other vaccine stocks are falling as Trump taps anti-vaxxer RFK Jr. for health secretary
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Canada approves Moderna's RSV vaccine, first of its kind for older adults
Health Canada approves Moderna's COVID-19 vaccine targeting latest variant
COVID-flu combo vaccine shows 'positive' results in phase 3 trials, Moderna says: A 'two-for' option
Moderna says its combination Covid and flu vaccine works well in late-stage trial
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
Moderna just got FDA approval for its RSV vaccine -- only its second product on the market
US government, Moderna nearing deal for bird flu vaccine funding: reports
Moderna halts plans to build Kenya vaccine plant as Covid shot demand plunges
Extract data
Extract all the news on this scope:
Visualize data
Trend on this scope:
Evolution through time
Source analysis:
Distribution of sources in the news
Section analysis:
Distribution of sections in the news
Current sentiment polarity: slightly positive (0.36)
| positive | 62% | |
| negative | 21% | |
| neutral | 17% |
Sentiment polarity through time
